Nachrichten zur Hims & Hers Health Inc. Aktie

Hims & Hers: A Game-Changer in Telehealth or Just Another Fad?

Is Hims & Hers the next big player in telehealth? Our experts break down its business model, growth potential, and…

Hims & Hers: A Game-Changer in Telehealth or Just Another Fad?

Is Hims & Hers the next big player in telehealth? Our experts break down its business model, growth potential, and…

Did You Lose Money on Hims & Hers Health, Inc. (HIMS)? Levi & Korsinsky Urges Investors to Act Before August 25, 2025

New York, New York--(Newsfile Corp. - August 7, 2025) - If you suffered a loss on your Hims & Hers…

Hims & Hers Health, Inc. (HIMS) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

/PRNewswire/ -- Glancy Prongay & Murray LLP announces that investors with losses have opportunity to lead the securities fraud class…

Hims & Hers Redefines Virtual Care With Integrated Tech Platforms

The renowned health and wellness platform, Hims & Hers Health, Inc. HIMS, has strategically prioritized the integration of technology platforms…

Hims & Hers: A High-Risk Bet (NYSE:HIMS)

Hims & Hers Health is upgraded to a speculative Buy after a 20% drop, with growth potential in GLP-1 sales…

HIMS LAWSUIT ALERT: The Gross Law Firm Notifies Hims & Hers Health, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline

/PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Hims & Hers Health, Inc. (NYSE: HIMS).…

Did You Lose Money on Hims & Hers Health, Inc. (HIMS)? Levi & Korsinsky Urges Investors to Act Before August 25, 2025

New York, New York--(Newsfile Corp. - August 7, 2025) - If you suffered a loss on your Hims & Hers...…

HIMS Shares Decline Amid Lower Revenue Per Order For GLP-1 Following Novo Nordisk Collaboration Termination, Securities Class Action Pending -- Hagens Berman

SAN FRANCISCO, Aug. 06, 2025 (GLOBE NEWSWIRE) -- On August 5, 2025, investors in Hims & Hers Health…

HIMS INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Hims & Hers Health, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

NEW YORK, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally…

Hims & Hers Health, Inc.: Please contact the Portnoy Law Firm to recover your losses. August 25, 2025 Deadline to file Lead Plaintiff Motion.

Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, Aug.…

Hims & Hers: Still Growing After Breakup With Novo Nordisk

…

Hims & Hers: Still Growing After Breakup With Novo Nordisk (NYSE:HIMS)

Hims & Hers is a top telehealth stock with strong revenue growth, innovative offerings, and long-term potential. Click here to…

Hims & Hers: GLP-1 Strategy Is On Dubious Grounds (NYSE:HIMS)

Hims & Hers Health showed a sharper-than-expected revenue hiccup in Q2, sending the stock down. Click here to find out…

Bank of America drops shocking price target on hot weight-loss stock post-earnings

The weight-loss boom wasn’t enough to save Hims & Hers from a concerning Wall Street call.…

Hims & Hers (HIMS) Falls 12.36% on Weaker Revenues

We recently published 10 Big Names Bleed Double Digits. Hims & Hers Health, Inc. (NYSE:HIMS) is one of the worst-performing…

Hims & Hers (HIMS) Falls 12.36% on Weaker Revenues

In its updated report, Hims & Hers Health, Inc.…

Hims & Hers Health, Inc. (HIMS) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

/PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with losses related to Hims & Hers Health,…

Diagnosis: Hims & Hers August Price Dip Is an Opportunity to Buy

Hims & Hers NYSE:HIMS August price dip is an opportunity to buy, but investors shouldn’t rush to get into this…

Diagnosis: Hims & Hers August Price Dip Is an Opportunity to Buy

Hims & Hers falls into a buying opportunity followng the Q2 release and guidance update but investors shouldnt rush to…

Contact Levi & Korsinsky by August 25, 2025 to Join Class Action Against Hims & Hers Health, Inc. (HIMS)

New York, New York--(Newsfile Corp. - August 6, 2025) - If you suffered a loss on your Hims & Hers...…

Novo Nordisk erhöht den Druck auf Hims & Hers und Co – Aktie bricht ein

Bereits am Montag nach US-Börsenschluss hat das Telehealth-Unternehmen Hims & Hers die Zahlen für das zweite Quartal vorgelegt und die…

Novo Nordisk erhöht den Druck auf Hims & Hers und Co – Aktie bricht ein

Bereits am Montag nach US-Börsenschluss hat das Telehealth-Unternehmen Hims & Hers die Zahlen für das zweite Quartal vorgelegt und die…

Hims & Hers Reports Strong Growth Amid Challenges

Hims & Hers Health, Inc. (($HIMS)) has held its Q2 earnings call. Read on for the main highlights of the…

HIMS & HERS HEALTH SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuits Against Hims & Hers Health, Inc.

NEW YORK and NEW ORLEANS, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and…

Why Hims & Hers Health (HIMS) Faces New Questions After Revenue Guidance Miss and Regulatory Setbacks

Hims & Hers Health, Inc. recently reported second quarter 2025 earnings, highlighting a significant year-over-year sales increase to US$544.83 million…

Hims & Hers Health stock falls as Novo Nordisk expands legal battle By Investing.com

Hims & Hers Health stock falls as Novo Nordisk expands legal battle…

Palantir, Pfizer, Hims & Hers, Intel, UnitedHealth: Stocks Making The Biggest Moves Today

U.S. equities declined in Tuesday’s midday trade after surging during the morning session, after President Donald Trump threatened to impose…

Hims & Hers Had a Tough Quarter. Weight-Loss Drugs Are Only One Problem.

Hims’ second-quarter revenue fell 7% from a quarter ago. The decline goes beyond weakness in its GLP-1 weight-loss business.…

Hims & Hers falls as weight loss treatment shift hurts revenues

Shares of Hims & Hers NYSE:HIMS fell nearly 9% on Tuesday after the telehealth firm reported weaker-than-expected quarterly revenue, in…

HIMS Stock Plunges Following Q2 Earnings Miss, Gross Margin Down

Hims & Hers misses second-quarter 2025 EPS and revenue estimates as gross margin narrows, despite strong online sales and subscriber…

Stock Movers: Palantir, Coinbase, Hims & Hers

Bloomberg journalists discuss todays biggest winners and losers in the stock market. Listen for analysis on the companies making news…

Hims & Hers Health Posts Weak Q2; Heading Into More Near-Term Challenges, Analysts Say - Hims & Hers Health (NYSE:HIMS)

Hims & Hers Health (HIMS) stock falls after reporting lower Q2 revenues. Analysts caution about near-term challenges, including regulatory complexity.…

Why Hims & Hers Health Stock Just Dropped

Hims & Hers stock just got cheaper -- and its still too expensive to buy.…

Hims & Hers Health, DuPont, Gartner: Trending Tickers

Hims & Hers Health (HIMS) stock is plunging after the telehealth company missed second quarter revenue estimates. DuPont (DD) stock…

Hims & Hers falls as declining subscriber base weighs on revenue

Shares of telehealth firm Hims & Hers NYSE:HIMS fell as much as 5% on Tuesday after the company reported weaker-than-expected…

Stock Movers: Palantir, Caterpillar, Hims & Hers, Vertex

Bloomberg journalists discuss todays biggest winners and losers in the stock market. Listen for analysis on the companies making news…

Hims & Hers stock slides 5% after second quarter revenue misses forecasts

Hims stock fell on Tuesday after posting a miss on analyst expectations in revenue for Q2.…

Hims & Hers stock slides 5% after second quarter revenue misses forecasts

…

Hims & Hers: Mixed Q2 Results Signal Valuation Concerns

Hims & Hers stock (NASDAQ: HIMS) declined approximately 13% in extended trading following Q2 results that showed strong growth but…

Hims & Hers Aktie: Rücksetzer nach Quartalszahlen - Jetzt noch kaufen? Aktienanalyse

San Francisco, CAFrankfurt (www.aktiencheck.de) - Hims & Hers Aktie: Rücksetzer nach Quartalszahlen - Jetzt noch kaufen? Aktienanalyse Die Hims & Hers…

Class Action Filed Against Hims & Hers Health, Inc. (HIMS) Seeking Recovery for Investors - Contact Levi & Korsinsky

/PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Hims & Hers Health, Inc. ("Hims & Hers Health, Inc." or…

Hims & Hers: Buy The Core Engine, Not The Headline (NYSE:HIMS)

Hims & Hers Healths Q2 revenue miss and decelerating growth triggered a stock drop. Find out why I maintain a…

Leerink Partners raises Hims and Hers stock price target to $43 on margin strength By Investing.com

Leerink Partners raises Hims and Hers stock price target to $43 on margin strength…

Hold Rating for Hims & Hers Health Amid Mixed Results and Growth Investments

Analyst Jonna Kim of TD Cowen maintained a Hold rating on Hims & Hers Health, boosting the price target to…

Hims & Hers Health Stock Plunges Over 13% In Tuesday Pre-Market: Whats Going On? - Hims & Hers Health (NYSE:HIMS), Eli Lilly (NYSE:LLY)

Hims & Hers Health Inc. (NYSE: HIMS) plunged 13.1% in Tuesday pre-market after the digital health company reported second-quarter revenue…

dpa-AFX ProFeed